A O Smith (AOS) is up more than 1% after Oppenheimer & Co upgraded the stock to outperform from market perform with a price target of $88. ELI Lilly (LLY) is down more than -7% to lead losers in the S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback